Forum Bourse NANOBIOTIX – 20/03/2025 21:27:51 – Cancer du poumon
Future Trends in Cancer Treatment: Spotlight on NANOBIOTIX’s Clinical Trial Updates As the medical community celebrates advances in oncology treatments, NANOBIOTIX, Inc. is poised to present crucial findings from its Phase 1 clinical trials on JNJ-1900 (NBTXR3) at the European Lung Cancer Congress. The trials focus on innovative approaches to treating recurrent, non-resectable lung cancer, … Read more